Enter Note Done
Go to previous page in this tab
Session
  • Presentation | ASH Poster Walk on New Developments in Targeted Therapies for Myeloid Malignancies Hosted by Blood Neoplasia
  • Scientific Program
  • Bookmark Icon
  • The Novel Pan-RAS Inhibitor ADT-007 Synergizes with FLT3 Inhibitors in FLT3-ITD AML Cells with RAS Activation Driven by Mutations or Constitutive FLT3-ITD Signaling...
  • Schedule
    Notes
  • Set Timezone
  •  
    Route Me

Generic 'disconnected' Message
ASH Poster Walks

Full Paper Title: The Novel Pan-RAS Inhibitor ADT-007 Synergizes with FLT3 Inhibitors in FLT3-ITD AML Cells with RAS Activation Driven by Mutations or Constitutive FLT3-ITD Signaling
Chatterjee:

Disclosure:
No relevant conflicts of interest to declare.

Co-Authors:
CME Status
Program
Main Session